Squamous Cell Carcinoma Clinical Trials

304 clinical trials for Squamous Cell Carcinoma across international registries, including 59 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer — RECRUITING · PHASE2
• Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors — RECRUITING · PHASE1
• The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas — RECRUITING · PHASE2
• A Study of IDP-001 in Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis — RECRUITING · PHASE1
• Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients — RECRUITING · NA
• PDT For Induction Therapy For Head And Neck Cancer — RECRUITING · PHASE2
• A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) — RECRUITING · PHASE1
• Prospective Data Collection Initiative on Thoracic Malignancies — RECRUITING
• Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION) — RECRUITING · PHASE2
• Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT) — RECRUITING · NA
• Spectroscopic Analysis of Tongue Tumor Samples. — RECRUITING
• A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers — RECRUITING · PHASE1
• Drug Screening of Cutaneous Lesions of Squamous Cell Carcinoma — RECRUITING · PHASE1
• Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery — RECRUITING · PHASE1
• Raman Spectroscopy and Skin Cancer — RECRUITING
• Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis — RECRUITING · NA
• Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN) — RECRUITING · PHASE2
• A PHASE 1 FIRST-IN-HUMAN, OPEN-LABEL STUDY EVALUATING THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF ABBV-711 AS A MONOTHERAPY OR IN COMBINATION WITH BUDIGALIMAB (ABBV-181) IN ADULT SUBJECTS WITH ADVANCED SQUAMOUS TUMORS — RECRUITING · PHASE1
• Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin — RECRUITING · PHASE2
• Patient Preference for Subcutaneous vs. Intravenous Immune Therapy — RECRUITING · PHASE2
• Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design — RECRUITING · PHASE2
• Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype — RECRUITING · NA
• A Study of VET3-TGI in Patients With Solid Tumors — RECRUITING · PHASE1
• Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC — RECRUITING · PHASE2
• Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA) — RECRUITING · PHASE2
• INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP) — RECRUITING · NA
• Use of SPY Imaging System to Minimize Fistulas After Hypopharyngeal Reconstruction — RECRUITING · PHASE2
• Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain — RECRUITING · NA
• A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment — RECRUITING · PHASE1
• Toripalimab With Chemotherapy for Sinus Cancer — RECRUITING · PHASE2
• Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck — RECRUITING · NA
• IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas — RECRUITING
• RANDOMIZED PHASE III TRIAL OF NEOADJUVANT IMMUNOTHERAPY WITH RESPONSE ADAPTED TREATMENT VERSUS STANDARD-OF-CARE TREATMENT FOR RESECTABLE STAGE III/IV CUTANEOUS SQUAMOUS CELL CARCINOMA — RECRUITING · PHASE3
• Early Diagnosis of Upper Digestive Tract Disease — RECRUITING
• BAI-BACE for Advanced Lung Squamous Cell Carcinoma — RECRUITING · NA
• A PHASE 2/3, ADAPTIVE, RANDOMIZED, OPEN-LABEL, CLINICAL STUDY TO EVALUATE NEOADJUVANT AND ADJUVANT V940 (MRNA-4157) IN COMBINATION WITH PEMBROLIZUMAB (MK-3475) VERSUS STANDARD OF CARE, AND PEMBROLIZUMAB MONOTHERAPY IN PARTICIPANTS WITH RESECTABLE LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA (LA CSCC) (INTERPATH-007) — RECRUITING · PHASE2
• Survival and Prognostic Factors of Squamous Cell Carcinoma of the Nasal Vestibule — RECRUITING
• NEOADJUVANT CHEMORADIOTHERAPY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA VERSUS DEFINITIVE CHEMORADIOTHERAPY WITH SALVAGE SURGERY AS NEEDED(NEEDS TRIAL) — RECRUITING
• A RANDOMIZED, CONTROLLED, OPEN-LABEL, PHASE 2 STUDY OF CEMIPLIMAB AS A SINGLE AGENT AND IN COMBINATION WITH RP1 IN PATIENTS WITH ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA — RECRUITING · PHASE2
• "A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF ADJUVANT CEMIPLIMAB VERSUS PLACEBO AFTER SURGERY AND RADIATION THERAPY IN PATIENTS WITH HIGH RISK CUTANEOUS SQUAMOUS CELL CARCINOMA." — RECRUITING
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE PEMBROLIZUMAB VERSUS PLACEBO AS ADJUVANT THERAPY FOLLOWING SURGERY AND RADIATION IN PARTICIPANTS WITH HIGH-RISK LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA (LA CSCC) (KEYNOTE-630) — RECRUITING · PHASE3
• A PHASE 1, OPEN-LABEL, DOSE ESCALATION STUDY OF MGA271 IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH MELANOMA, SQUAMOUS CELL CANCER OF THE HEAD AND NECK, NON-SMALL CELL LUNG CANCER, UROTHELIAL CANCER, AND OTHER CANCERS — RECRUITING · PHASE1
• A PHASE 2, OPEN-LABEL, SINGLE ARM STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PEMBROLIZUMAB IN PARTICIPANTS WITH RECURRENT OR METASTATIC CUTANEOUS SQUAMOUS CELL CARCINOMA (R/M CSCC) — RECRUITING · PHASE2
• PRE-OPERATIVE MOCETINOSTAT (MGCD0103) AND DURVALUMAB (MEDI4736) (PRIMED) FOR SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY — RECRUITING
• DEFINING A PERSONALIZED HYPOXIC RADIATION TARGET THROUGH CORRELATION OF FUNCTIONAL F18-FAZA PET IMAGING TO PIMONIDAZOLE-STAINED 3D WHOLE-MOUNTED HISTOLOGICAL SPECIMEN — RECRUITING
• A RANDOMIZED PHASE 2 TRIAL OF NEOADJUVANT AND ADJUVANT THERAPY WITH THE IRX-2 REGIMEN IN PATIENTS WITH NEWLY DIAGNOSED STAGE II, III AND IVA SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY — RECRUITING · PHASE2
• A PHASE III RANDOMIZED, OPEN-LABEL, MULTI-CENTER, GLOBAL STUDY OF MEDI4736 IN COMBINATION WITH TREMELIMUMAB VERSUS STANDARD OF CARE IN THE TREATMENT OF FIRST-LINE RECURRENT OR METASTATIC SQUAMOUS CELL HEAD AND NECK CANCER PATIENTS — RECRUITING · PHASE3

Refine this search